Anthera Announces Additional Data from the Phase 2b PEARL-SC Presented at the ACR/ARHP 2012 Annual Scientif... ( HAYWARD Calif. Nov. 13 2012 /- Anther...)

Anthera Announces Additional Data from the Phase 2b PEARL-SC Presented at the ACR/ARHP 2012 Annual Scientific Meeting

Date:11/13/2012

HAYWARD, Calif., Nov. 13, 2012 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation and autoimmune disorders, today announced additional data from its Phase 2b PEARL-SC study presented in a late breaking poster at the 2012 Annual Scientific Meeting of the American College of Rheumatology and the Association of Rheumatology Health Professionals (ACR/ARHP). The poster entitled "Blisibimod, an Inhibitor of B cell Activating Factor, in Patients with Moderate-to-Severe Systemic Lupus Erythematosus," was presented by Dr. Richard Furie, MD, on Tuesday, November 13, 2012. Dr. Furie is Chief of the Division of Rheumatology and Allergy-Clinical Immunology at the North Shore-Long Island Jewish Health System and directs the hospital's Systemic Lupus Erythematosus (SLE) and Autoimmune Disease Treatment Center.

The poster highlights data from the PEARL-SC clinical study including new information regarding treatment effects in the broader modified intent to treat population of lupus patients where 200 mg weekly blisibimod therapy was associated with statistically significant benefits in predefined SLE Responder Index (SRI*) endpoints. Specifically, this new data indicates statistically significant treatment effects using higher thresholds of improvement in disease score (SELENA/SLEDAI** reductions of 7 and 8) including the recently FDA reviewed SRI-8 endpoint to be utilized in the phase 3 CHABLIS-SC clinical studies. These data confirm and expand on previously reported clinical improvements seen in the population of patients to be enrolled in the CHABLIS-SC phase 3 clinical studies. These studies will enroll patients with active disease (SELENA/SLEDAI > 10) who are also receiving corticosteroid therapy at baseline.

As well, the poster highlighted the positive effect
'/>"/>

SOURCE Anthera Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4
Related medicine technology :

1. Anthera Announces the Phase 2b PEARL-SC Data Has Been Accepted as a Late Breaking Poster Presentation at the ACR/ARHP 2012 Annual Scientific Meeting
2. Anthera Announces the Advancement of Blisibimod into Phase 3 Development for Patients with Systemic Lupus Erythematosus (SLE)
3. Anthera Pharmaceuticals Reports 2012 Second Quarter Financial Results And Provides Clinical Progress Update
4. Anthera Pharmaceuticals Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Common Stock
5. Anthera Pharmaceuticals Announces Pricing of Public Offering of Common Stock
6. Anthera Pharmaceuticals Announces Proposed Public Offering of Common Stock
7. Anthera Pharmaceuticals Provides Additional Data from the Recently Completed PEARL-SC Study of Blisibimod in the Proposed Phase 3 Population
8. Anthera Pharmaceuticals to Present at the 7th Annual JMP Securities Healthcare Conference
9. Anthera Updates Phase 3 Plans Following Results from the Phase 2b PEARL-SC Dose Ranging Study of Blisibimod
10. Anthera Pharmaceuticals Reports 2012 First Quarter Financial Results And Provides Clinical Progress Update
11. Anthera Announces First Quarter 2012 Financial Report and Conference Call

Post Your Comments:

(Date:5/24/2013)... An international roster of experts on malignant pleural ... Santa Monica, Calif. , to discuss their ... a rare form of cancer that results from exposure ... of the chest. Hosted by UCLA and ... Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural ...

(Date:5/24/2013)... YORK , May 24, 2013 In accordance ... Rules and Rule 14e-1 of the United States Exchange Act, ... its original offer for Elan Corporation (NYSE: ELN). ... Limited ("Royalty Pharma") made an offer for the entire of ... Corporation, plc ("Elan") (the "Original Offer"). On ...

(Date:5/23/2013)... , May 24, 2013 3SBio Inc. ... "Company"), a leading China -based ... marketing biopharmaceutical products, announced today that, at an ... Company,s shareholders voted in favor of the proposal ... and plan of merger dated February 8, 2013, ...

Breaking Medicine Technology:International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma 2 International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma 3 Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 2 Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 3 Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 4 Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 5 Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 6 Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 7 Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 8 Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 9 3SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 2 3SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 3

[0] International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma [0] Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements [0] 3SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement

... , SALT LAKE CITY, Nov. 24 ... launch of a new online vision therapy program eyeQ, the software program ... eyeQ was introduced at the COVD conference this October in ... program adds significant value to his practice, Sensory Learning Center in ...

... ... companies are testing 97 medicines and vaccines to treat or prevent ... by the Pharmaceutical Research and Manufacturers of America (PhRMA). December 1 ... awareness campaign that originated at the 1988 World Summit of Ministers ...

Cached Medicine Technology:Infinite Mind Announces the Launch of a New Online Vision Therapy Program eyeQ 2 New Report Shows 97 Medicines and Vaccines Currently in Development for HIV/AIDS 2 New Report Shows 97 Medicines and Vaccines Currently in Development for HIV/AIDS 3

Infinite Mind Announces the Launch of a New Online Vision Therapy Program eyeQ New Report Shows 97 Medicines and Vaccines Currently in Development for HIV/AIDS

(Date:5/25/2013)... BC (PRWEB) May 25, 2013 According ... the most beautiful and powerful women that ever lived. ... felt by some of the most powerful men in ... many beauty remedies to keep her skin glowing and ... made with bees- wax, maringa oil and cyprus grass. ...

(Date:5/25/2013)... May 25, 2013 For college ... finals week. Increasingly, they are turning to prescription ... and study. For more on this, go to ... treatment facility, warns that students who pick up ... at risk for developing a physical and psychological ...

(Date:5/25/2013)... May 25, 2013 HealthCrave Medical ... is unique in that it doesn’t just focus ... on treating what causes the noticeable signs of ... Dr. James D. Weiss, M.D., the center provides ... process while helping patients to live longer, healthier ...

(Date:5/24/2013)... A recent study by research group Harris ... upcoming bathing suit season. Almost 138 million people are fearful ... due to weight issues and a quarter admit they feel ... Labs recommends that those anxious about their size consider the ... of an overall effort to improve diet and exercise habits ...

(Date:5/24/2013)... 24, 2013 Compromise is often cited as ... it comes to sleep and comfort. However, many couples find ... individual. For some, this can cause added stress, lost sleep, ... blog, tackles eight common issues in their latest article on ... He Wants Firm: What to do When You Disagree on ...

Breaking Medicine News(10 mins):Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 2 Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 3 Health News:Addiction and Drug Abuse: Study Drug Adderall Abuse Spikes During Finals 2 Health News:Anti-Aging Center Offers Advanced Treatment that Controls the Aging Process from Within 2 Health News:PhenObestin 37.5 Can Help Make Bathing Suit Season Less Stressful 2 Health News:PhenObestin 37.5 Can Help Make Bathing Suit Season Less Stressful 3 Health News:What’s The Best Bed Offers Mattress & Sleep Solutions for Opposite Couples 2

[0] The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician [0] Addiction and Drug Abuse: Study Drug Adderall Abuse Spikes During Finals [0] Anti-Aging Center Offers Advanced Treatment that Controls the Aging Process from Within [0] PhenObestin 37.5 Can Help Make Bathing Suit Season Less Stressful [0] What’s The Best Bed Offers Mattress & Sleep Solutions for Opposite Couples

... Weight Watchers program and obesity training, state,s,largest Medicaid managed ... Association to provide medical professionals the opportunity to ... in conducting Breathe Well, Live Well program, CHARLESTON, ... among the highest in the country in asthma prevalence,UniCare ...

... and HONOLULU, March 12 Allscripts,the leading ... that physicians use to improve healthcare, today ... that provides,technology and support services to more ... statewide license for the Allscripts Electronic Health,Record ...

... in 30% of middle schoolers studied, blamed on acids ... News) -- Dental erosion -- the loss of the ... the United States, researchers say. , "This study is ... prevalence of dental erosion in this country and, more ...

... March 12 As part of its ongoing ... decision-making,Independence Blue Cross today announced that four area ... Complex and Rare Cancers(SM)., Blue Distinction(R) is ... to make wise health care decisions and to ...

... Campaign Features "Superheroes" Theme, WASHINGTON, March 12 ... Agency for Healthcare Research and Quality,(AHRQ) joined with ... public service campaign designed to encourage,Hispanics to become ... urges,Hispanics to stay healthy for their loved ones ...

... TORONTO, March 12 /PRNewswire-FirstCall/ - Bradmer ... the development and,commercialization of cancer therapies, today ... operational and financial results., Operational Highlights, ... 2007, the Company achieved the,following steps in ...

UniCare of West Virginia Providing Assistance for Asthma Education Training Hawaii's Premier Physician Management Company, TeamPraxis, Selects Allscripts Electronic Health Record for Statewide Deployment Dental Erosion on Rise in U.S.Independence Blue Cross Announces Blue Distinction Centers for Complex and Rare Cancers(SM) in Philadelphia AHRQ and Ad Council Encourage Hispanics to Become More Involved in Their Health Care Bradmer announces 2007 fourth quarter and fiscal year operational and financial results

Inquire...

Glucose tubes contain an anti-coagulant and a stabiliser. The tubes are ideal for glucose and lactate determinations....

BD Vacutainer® Fluoride Tubes - Glass...

VACUETTE Trace Element tubes - Ridged (safety screw cap) are designed to test trace elements such as Cu, Zn, Pb, etc....

Medicine Products:

MONOJECT Grey Stopper VACUETTE Glucose tubes - Non-ridged (pull cap)BD Vacutainer® Fluoride (Glucose) Tubes - Glass VACUETTE Trace Element tubes - Ridged (safety screw cap)